Donate

Age Related Macular Degeneration

SEARCH BY:
Type
Disease
Program
Reset Filters
Clinical Trials
August 26, 2021

Age-Related Macular Degeneration Happenings at the Foundation

At the Retina Foundation, our Laboratory Directors often partner with various pharmaceutical and biotechnology companies to conduct clinical trials and research. In our Clinical Center of Innovation for Age-Related Macular Degeneration (AMD), led by Karl Csaky, M.D., Ph.D., Chief Executive and Medical Officer of the Foundation, we currently have 15 studies for AMD and geographic […]

READ MORE
Clinical Research
May 15, 2020

In-Depth Vision Evaluations & Research Updates for Retinal Diseases – Video Update

Yi-Zhong Wang, Ph.D., Director, Macular Function Laboratory, discusses visual function and imaging evaluation for patients with retinal diseases and his deep machine learning project in the video update below. This update is relevant for those interested in learning more about our research for age-related macular degeneration, diabetic retinopathy, and other inherited eye diseases. Should you […]

READ MORE
Laboratory Research
April 24, 2020

Developing a Treatment for Age-Related Macular Degeneration – Video Update

In this video, Tim Catchpole, Ph.D., Senior Research Associate, Molecular Ophthalmology Laboratory, provides a brief overview of age-related macular degeneration (AMD) and shares how we are developing a novel treatment for AMD. Should you have any questions, please call us at 214.363.3911 or email us at development@retinafoundation.org. We welcome your questions and feedback and look […]

READ MORE
Patient Resource
April 9, 2020

Retina Foundation 20/20 Video Research Updates

The Retina Foundation is pleased to share 20/20 video updates as we continue to move forward with our cutting-edge research, reading, planning experiments, analyzing data, and drafting new grant proposals as we telecommute. Introduction Video by Dr. Karl Csaky, CEO – April 9, 2020 Clinical Research in Age-Related Macular Degeneration – April 10, 2020 Investigating […]

READ MORE
Laboratory Research
September 26, 2019

The Effectiveness of Therapeutic Drugs for AMD in the Laboratory

Ruvanthi Kularatne, Ph.D., is a Postdoctoral Fellow at the Retina Foundation of the Southwest, working under the direction of Karl Csaky, M.D., Ph.D., Managing & Medical Director. Dr. Kularatne has spent the past year evaluating the effectiveness of therapeutic drugs, and their impact on treatment for age-related macular degeneration (AMD). Currently, our researchers are working […]

READ MORE
News/ Press Release
July 19, 2019

FFB Pledges $300,000 to Support Dr. Yi-Zhong Wang’s Artificial Intelligence/ Deep Machine Learning Project

Yi-Zhong Wang, Ph.D., Scientific Director, Macular Function Laboratory, is working to achieve automatic and accurate identification of defects in the structure of patients’ retinas by applying deep machine learning method. Over the past year, using a cutting-edge computer system, Dr. Wang has been training a deep convolutional neural network model to learn how to detect […]

READ MORE
Laboratory Research
May 16, 2019

Discovering New Therapies for AMD

The Molecular Ophthalmology Laboratory, under the direction of Dr. Karl Csaky, Managing & Medical Director at the Retina Foundation of the Southwest, is studying live cell cultures to investigate new potential drug treatments for age-related macular degeneration (AMD). Live cultures offer a quick and scalable solution for testing new drugs and therapies for AMD. Here, […]

READ MORE
Clinical Trials
November 7, 2018

Phase III Treatment Trial for Stargardt Disease Enrolls First Patient

The Retina Foundation of the Southwest was the first site in the world to enroll patients in a new international Phase III Clinical Treatment Trial for Stargardt Disease sponsored by the clinical-stage ophthalmology company Acucela. This study is a phase III treatment trial to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (“emixustat”), as a treatment […]

READ MORE
1 2 3